非侵襲的出生前検査の市場規模、シェア、動向分析レポート：妊娠期間別、妊娠リスク別、方法別、技術別、製品別、用途別、最終用途別、地域別、セグメント予測：2024年～2030年

非侵襲的出生前検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の非侵襲的出生前検査の市場規模は、2030年までに81億6,000万米ドルに達し、2024年から2030年までのCAGRは10.06％で拡大する見込みです。

染色体異常の発生率の増加が市場成長を加速すると予想されます。すべての国の中で、年間出生数は1,465万人近くで、ハイリスク妊娠が増加している中国には、非侵襲的出生前スクリーニングの大きな機会があります。

また、インドでは遺伝性疾患の負担が大きいです。様々な研究によると、同国では新生児166人に1人の頻度で染色体異常が見つかっており、トリソミー21（ダウン症）は800人に1人という高い発生率で、毎年32,000人のダウン症の新生児が誕生しています。NIPTを用いた正確で早期のスクリーニングにより、家族は赤ちゃんの遺伝的問題を知ることができます。したがって、この高い発生率は出生前検査の需要を高めると予想されます。

絨毛膜絨毛サンプリングや羊水穿刺のような侵襲的な方法は入院を必要とし、患者や医療関係者がCOVID-19に感染する危険性があります。さらに、NIPTの処方に対する需要が高まっていますが、ほとんどの国ではインフラが整っておらず、遠隔医療施設も導入されていないため、対象となる人の数は限られています。

非侵襲的出生前検査に関する償還シナリオは非常に多様です。しかし、政府からの支援と有利な保険政策が市場の成長を後押ししています。例えば、オランダでは出生前検査の費用は妊娠第2期に全額償還されるため、これらの検査の採用が増加しています。インドや中国などの新興国におけるバイオ・製薬業界を奨励する政府のイニシアチブの増加は、非侵襲的出生前検査ソリューションとサービスの需要を押し上げると予想されます。

市場の主なプレーヤーは、製品ポートフォリオを強化し、顧客に革新的な製品を提供するために新製品開拓に注力しています。2020年3月、Agilent Technologiesは、細胞遺伝学研究所による出生前・出生後研究をサポートする3つの新しいマイクロアレイを発売しました。サイトーマイクロアレイのプローブは、体質DNAサンプルにおける神経精神疾患、発達遅延、知的障害、先天異常などに関連するコピー数変異やコピーニュートラルヘテロ接合性喪失を高分解能で検出します。

非侵襲的出生前検査市場レポートハイライト

• 妊娠期間別では、妊娠第2期に実施される非侵襲的出生前処置の数が最大であることから、2023年には13週から24週が市場を独占しました。
• 妊娠リスクの低いセグメントは予測期間中に大幅な成長が見込まれます。平均的リスクの妊娠に対する予算割り当てなどの政府からの支援が、このセグメントの成長に寄与しています。
• 製品別では、母体血漿中の無細胞DNA検査セグメントが2023年に最大の収益シェアを占めました。無細胞DNAは、様々な遺伝子分析を通じて、出生前ケアにおける遺伝性疾患のリスク予測にますます活用されるようになっています。
• アジア太平洋地域は予測期間中に最も高いCAGRを示すと予想されています。妊産婦年齢の上昇とヘルスケアインフラの向上が市場成長を強化するとみられます。
• 北米は、高い研究開発投資、高度なヘルスケア施設の存在、全ゲノムシーケンスの発展により、2023年の市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
• 市場促進要因
  • 母親の平均年齢の上昇と染色体症候群の発生率の増加
  • 早期かつ非侵襲的な胎児検査手順に対する高い需要
  • 償還シナリオの改善
  • コラボレーションとライセンシング契約の増加
• 市場抑制要因分析
  • 生殖遺伝学に関する倫理的懸念
• 事業環境分析
  • SWOT分析；要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 妊娠期のビジネス分析

• 非侵襲的出生前検査市場：妊娠期間の変動分析
• 0～12週間
  • 0～12週間の非侵襲的出生前検査市場、2018年～2030年
• 13～24週間
  • 13～24週間の非侵襲的出生前検査市場、2018年～2030年
• 25～36週間
  • 25～36週間の非侵襲的出生前検査市場、2018年～2030年

第5章 妊娠リスクのビジネス分析

• 非侵襲的出生前検査市場：妊娠リスクの変動分析
• 高リスクおよび平均リスク
  • 高リスクおよび平均リスクの非侵襲的出生前検査市場、2018年～2030年
• 低リスク
  • 低リスク非侵襲的出生前検査市場、2018年～2030年

第6章 方法リスクのビジネス分析

• 非侵襲的出生前検査市場：手法の変動分析
• 超音波検出
  • 超音波検出非侵襲的出生前検査市場、2018年～2030年
• 生化学的スクリーニング検査
  • 生化学的スクリーニング検査の非侵襲的出生前検査市場、2018年～2030年
• 母体血漿検査における無細胞 DNA
  • 母体血漿検査における無細胞 DNA非侵襲的出生前検査市場、2018年～2030年

第7章 技術リスクのビジネス分析

• 非侵襲的出生前検査市場：技術変動分析
• NGS
  • NGSの非侵襲的出生前検査市場、2018年～2030年
• アレイテクノロジー
  • アレイテクノロジーの非侵襲的出生前検査市場、2018年～2030年
• PCR
  • PCRの非侵襲的出生前検査市場、2018年～2030年
• その他
  • その他の非侵襲的出生前検査市場、2018年～2030年

第8章 製品リスクのビジネス分析

• 非侵襲的出生前検査市場：製品変動分析
• 消耗品と試薬
  • 消耗品と試薬の非侵襲的出生前検査市場、2018年～2030年
• 機器
  • 機器の非侵襲的出生前検査市場、2018年～2030年

第9章 アプリケーションリスクのビジネス分析

• 非侵襲的出生前検査市場：アプリケーションの変動分析
• トリソミー
  • トリソミーの非侵襲的出生前検査市場、2018年～2030年
• 微小欠失症候群
  • 微小欠失症候群の非侵襲的出生前検査市場、2018年～2030年
• その他
  • その他の非侵襲的出生前検査市場、2018年～2030年

第10章 最終用途のビジネス分析

• 非侵襲的出生前検査市場：最終用途の変動分析
• 病院とクリニック
  • 病院とクリニック市場、2018年～2030年
• 診断研究所
  • 診断研究所市場、2018年～2030年
• 学術・研究機関
  • 学術・研究機関の市場、2018年～2030年

第11章 地域ビジネス分析

• 地域別の非侵襲的出生前検査市場シェア、2023年・2030年
• 北米
  • 北米の非侵襲的出生前検査市場、2018年～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州の非侵襲的出生前検査市場、2018年～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の非侵襲的出生前検査市場、2018年～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの非侵襲的出生前検査市場、2018年～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの非侵襲的出生前検査市場、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第12章 競合情勢

• 参入企業の概要
• 財務実績
• 参入企業
  • マーケットリーダー
  • 非侵襲的出生前検査市場シェア分析、2023年
  • 企業プロファイル
  • 戦略マッピング

List of Tables

• TABLE 1 List of secondary sources
• TABLE 2 List of abbreviations
• TABLE 3 Regulatory framework
• TABLE 4 Risk of Trisomy 21 and chromosomal abnormalities with maternal age
• TABLE 5 Average selling prices of non-invasive prenatal tests
• TABLE 6 North America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
• TABLE 7 North America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 8 North America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 9 North America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 10 North America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 11 North America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 12 North America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 13 North America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 14 U.S. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 15 U.S. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 16 U.S. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 17 U.S. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 18 U.S. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 19 U.S. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 20 U.S. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 21 Canada NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 22 Canada NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 23 Canada NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 24 Canada NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 25 Canada NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 26 Canada NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 27 Canada NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 28 Europe NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
• TABLE 29 Europe NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 30 Europe NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 31 Europe NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 32 Europe NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 33 Europe NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 34 Europe NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 35 Europe NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 36 U.K. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 37 U.K. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 38 U.K. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 39 U.K. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 40 U.K. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 41 U.K. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 42 U.K. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 43 Germany NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 44 Germany NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 45 Germany NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 46 Germany NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 47 Germany NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 48 Germany NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 49 Germany NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 50 France NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 51 France NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 52 France NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 53 France NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 54 France NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 55 France NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 56 France NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 57 Italy NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 58 Italy NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 59 Italy NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 60 Italy NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 61 Italy NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 62 Italy NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 63 Italy NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 64 Spain NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 65 Spain NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 66 Spain NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 67 Spain NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 68 Spain NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 69 Spain NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 70 Spain NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 71 Denmark NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 72 Denmark NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 73 Denmark NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 74 Denmark NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 75 Denmark NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 76 Denmark NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 77 Denmark NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 78 Sweden NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 79 Sweden NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 80 Sweden NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 81 Sweden NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 82 Sweden NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 83 Sweden NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 84 Sweden NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 85 Norway NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 86 Norway NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 87 Norway NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 88 Norway NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 89 Norway NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 90 Norway NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 91 Norway NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 92 Asia Pacific NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
• TABLE 93 Asia Pacific NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 94 Asia Pacific NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 95 Asia Pacific NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 96 Asia Pacific NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 97 Asia Pacific NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 98 Asia Pacific NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 99 Asia Pacific NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 100 Japan NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 101 Japan NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 102 Japan NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 103 Japan NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 104 Japan NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 105 Japan NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 106 Japan NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 107 China NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 108 China NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 109 China NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 110 China NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 111 China NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 112 China NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 113 China NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 114 India NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 115 India NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 116 India NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 117 India NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 118 India NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 119 India NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 120 India NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 121 South Korea NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 122 South Korea NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 123 South Korea NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 124 South Korea NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 125 South Korea NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 126 South Korea NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 127 South Korea NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 128 Australia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 129 Australia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 130 Australia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 131 Australia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 132 Australia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 133 Australia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 134 Australia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 135 Thailand NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 136 Thailand NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 137 Thailand NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 138 Thailand NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 139 Thailand NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 140 Thailand NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 141 Thailand NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 142 Latin America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
• TABLE 143 Latin America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 144 Latin America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 145 Latin America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 146 Latin America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 147 Latin America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 148 Latin America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 149 Latin America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 150 Brazil NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 151 Brazil NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 152 Brazil NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 153 Brazil NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 154 Brazil NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 155 Brazil NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 156 Brazil NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 157 Mexico NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 158 Mexico NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 159 Mexico NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 160 Mexico NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 161 Mexico NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 162 Mexico NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 163 Mexico NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 164 Argentina NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 165 Argentina NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 166 Argentina NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 167 Argentina NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 168 Argentina NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 169 Argentina NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 170 Argentina NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 171 MEA NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
• TABLE 172 MEA NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 173 MEA NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 174 MEA NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 175 MEA NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 176 MEA NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 177 MEA NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 178 MEA NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 179 South Africa NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 180 South Africa NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 181 South Africa NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 182 South Africa NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 183 South Africa NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 184 South Africa NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 185 South Africa NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 186 Saudi Arabia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 187 Saudi Arabia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 188 Saudi Arabia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 189 Saudi Arabia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 190 Saudi Arabia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 191 Saudi Arabia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 192 Saudi Arabia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 193 UAE NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 194 UAE NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 195 UAE NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 196 UAE NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 197 UAE NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 198 UAE NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 199 UAE NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
• TABLE 200 Kuwait NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
• TABLE 201 Kuwait NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
• TABLE 202 Kuwait NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
• TABLE 203 Kuwait NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
• TABLE 204 Kuwait NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
• TABLE 205 Kuwait NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• TABLE 206 Kuwait NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures

• FIG. 1 Market research process
• FIG. 2 Information Procurement
• FIG. 3 Primary Research Pattern
• FIG. 4 Market Research Approaches
• FIG. 5 Value Chain-Based Sizing & Forecasting
• FIG. 6 Market Formulation & Validation
• FIG. 7 Non-Invasive Prenatal Testing Market Segmentation
• FIG. 8 Market Snapshot, 2023
• FIG. 9 Market Trends & Outlook
• FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
• FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• FIG. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
• FIG. 13 Porter's Five Forces Analysis
• FIG. 14 Global Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
• FIG. 15 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, 2018 - 2030 (USD Million)
• FIG. 16 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, 2018 - 2030 (USD Million)
• FIG. 17 Global Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
• FIG. 18 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, 2018 - 2030 (USD Million)
• FIG. 19 Global Non-Invasive Prenatal Testing Market, by Low Risk, 2018 - 2030 (USD Million)
• FIG. 20 Global Non-Invasive Prenatal Testing Market: Method Movement Analysis
• FIG. 21 Global Non-Invasive Prenatal Testing Market, by Ultrasound Detection, 2018 - 2030 (USD Million)
• FIG. 22 Global Non-Invasive Prenatal Testing Market, by Biochemical Screening Tests, 2018 - 2030 (USD Million)
• FIG. 23 Global Non-Invasive Prenatal Testing Market, by Cell-free DNA in Maternal Plasma Tests, 2018 - 2030 (USD Million)
• FIG. 24 Global Non-Invasive Prenatal Testing Market: Technology Movement Analysis
• FIG. 25 Global Non-Invasive Prenatal Testing Market, by NGS, 2018 - 2030 (USD Million)
• FIG. 26 Global Non-Invasive Prenatal Testing Market, by Array Technology, 2018 - 2030 (USD Million)
• FIG. 27 Global Non-Invasive Prenatal Testing Market, by PCR, 2018 - 2030 (USD Million)
• FIG. 28 Global Non-Invasive Prenatal Testing Market, by Others, 2018 - 2030 (USD Million)
• FIG. 29 Global Non-Invasive Prenatal Testing Market: Product Movement Analysis
• FIG. 30 Global Non-Invasive Prenatal Testing Market, by Consumables & Reagents, 2018 - 2030 (USD Million)
• FIG. 31 Global Non-Invasive Prenatal Testing Market, by Instruments, 2018 - 2030 (USD Million)
• FIG. 32 Global Non-Invasive Prenatal Testing Market: Application Movement Analysis
• FIG. 33 Global Non-Invasive Prenatal Testing Market, by Trisomy, 2018 - 2030 (USD Million)
• FIG. 34 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, 2018 - 2030 (USD Million)
• FIG. 35 Global Non-Invasive Prenatal Testing Market, by Other Applications, 2018 - 2030 (USD Million)
• FIG. 36 Global Non-Invasive Prenatal Testing Market: End-use Movement Analysis
• FIG. 37 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, 2018 - 2030 (USD Million)
• FIG. 38 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, 2018 - 2030 (USD Million)
• FIG. 39 Regional Marketplace: Key Takeaways
• FIG. 40 Regional Outlook, 2023 & 2030
• FIG. 41 Global Non-Invasive Prenatal Testing Market: Region Movement Analysis
• FIG. 42 North America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 43 U.S. Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 44 Canada Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 45 Europe Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 46 Germany Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 47 UK Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 48 France Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 49 Italy Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 50 Spain Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 51 Denmark Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 52 Sweden Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 53 Norway Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 54 Asia Pacific Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 55 Japan Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 56 China Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 57 India Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 58 Australia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 59 South Korea Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 60 Thailand Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 61 Latin America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 62 Brazil Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 63 Mexico Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 64 Argentina Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 65 Middle East and Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 66 South Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 67 Saudi Arabia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 68 UAE Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• FIG. 69 Kuwait Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Non Invasive Prenatal Testing Market Growth & Trends:

The global non invasive prenatal testing market size is expected to reach USD 8.16 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.06% from 2024 to 2030. Increasing incidence of chromosomal abnormalities is expected to accelerate market growth. Of all the countries, there is a substantial opportunity in China for non invasive prenatal screening, with nearly 14.65 million annual births and increasing number of high-risk pregnancies.

In addition, India has a heavy burden of genetic diseases. Various studies suggested that chromosomal abnormalities are found with a frequency of 1 in 166 newborns in the country, while trisomy 21 (Down syndrome) has a high incidence rate of 1 in 800 births, resulting in the birth of 32,000 newborns with Down syndrome every year. Families can benefit from accurate and early screening using NIPT to know about their baby's genetic issue. Thus, this high incidence rate is anticipated to boost the demand for prenatal tests.

With lockdowns due to COVID-19, NIPT gained attention because it delivers high accuracy screening with minimum risk of infection compared to invasive procedures like chorionic villus sampling and amniocentesis, both of which may necessitate hospitalization and put patients and medical professionals at risk of contracting COVID-19 infection. Moreover, there was increased demand for prescription of NIPTs; however, it was limited to a smaller number of eligible people due to the lack of infrastructure and adoption of telemedicine facilities in most countries.

The reimbursement scenario pertaining to non invasive prenatal testing is highly variable. However, the support from the government and favorable insurance policies boost market growth. For instance, in the Netherlands, prenatal testing expenses are fully reimbursed in the second trimester, leading to increased adoption of these tests. Increase in government initiatives to encourage the bio- and pharmaceutical industry in emerging economies such as India and China is anticipated to boost the demand for noninvasive prenatal testing solutions and services.

Key players in the market are focusing on new product development to strengthen their product portfolios and offer innovative products to customers. In March 2020, Agilent Technologies launched three new microarrays to support prenatal and postnatal research by cytogenetic laboratories. The probes on the cyto microarrays offer high-resolution detection of copy number variation and copy-neutral loss of heterozygosity related to neuropsychiatric disorders, developmental delay, intellectual disability, and congenital anomalies in constitutional DNA samples.

Non Invasive Prenatal Testing Market Report Highlights:

• By gestation period, 13-24 weeks dominated the market in 2023 owing to the maximum number of non-invasive prenatal procedures carried out in the second trimester of the pregnancy
• The low-risk pregnancy risk segment is expected to witness significant growth over the forecast period. Support from the government such as budget assignment for average-risk pregnancies contributed to the segment growth
• Based on product, the cell-free DNA in maternal plasma tests segment accounted for the largest revenue share in 2023. Cell-free DNA is increasingly being utilized in predicting the risk of genetic disorders in prenatal care via various genetic analyses
• Asia Pacific is expected to exhibit the highest CAGR over the forecast period. Rising maternal age and improving healthcare infrastructure are likely to strengthen the market growth
• North America dominated the market in 2023 due to high R&D investments, the presence of advanced healthcare facilities, and the development of whole genome sequencing

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. Objective - 1
  • 1.2.2. Objective - 2
  • 1.2.3. Objective - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. Gvr's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers
  • 3.4.1. Increasing average maternal age and rising incidence of chromosomal syndromes
  • 3.4.2. High demand for early and noninvasive fetal testing procedure
  • 3.4.3. Improvements in the reimbursement scenario
  • 3.4.4. Rising collaborations and licensing agreements
• 3.5. Market Restraint Analysis
  • 3.5.1. Ethical concerns with respect to reproductive genetics
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Gestation Period Business Analysis

• 4.1. Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
• 4.2. 0-12 Weeks
  • 4.2.1. 0-12 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 4.3. 13-24 Weeks
  • 4.3.1. 13-24 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 4.4. 25-36 Weeks
  • 4.4.1. 25-36 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Pregnancy Risk Business Analysis

• 5.1. Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
• 5.2. High & Average Risk
  • 5.2.1. High & Average Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 5.3. Low Risk
  • 5.3.1. Low Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Method Risk Business Analysis

• 6.1. Non-Invasive Prenatal Testing Market: Method Movement Analysis
• 6.2. Ultrasound Detection
  • 6.2.1. Ultrasound Detection Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 6.3. Biochemical Screening Tests
  • 6.3.1. Biochemical Screening Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 6.4. Cell-free DNA in Maternal Plasma Tests
  • 6.4.1. Cell-free DNA in Maternal Plasma Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 7. Technology Risk Business Analysis

• 7.1. Non-Invasive Prenatal Testing Market: Technology Movement Analysis
• 7.2. NGS
  • 7.2.1. NGS Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 7.3. Array Technology
  • 7.3.1. Array Technology Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 7.4. PCR
  • 7.4.1. PCR Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Product Risk Business Analysis

• 8.1. Non-Invasive Prenatal Testing Market: Product Movement Analysis
• 8.2. Consumables & Reagents
  • 8.2.1. Consumables & Reagents Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 8.3. Instruments
  • 8.3.1. Instruments Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Application Risk Business Analysis

• 9.1. Non-Invasive Prenatal Testing Market: Application Movement Analysis
• 9.2. TRISOMY
  • 9.2.1. TRISOMY Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 9.3. Microdeletion Syndrome
  • 9.3.1. Microdeletion Syndrome Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
• 9.4. Others
  • 9.4.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 10. End-use Business Analysis

• 10.1. Non-Invasive Prenatal Testing Market: End-Use Movement Analysis
• 10.2. Hospitals & Clinics
  • 10.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 10.3. Diagnostics Laboratories
  • 10.3.1. Diagnostics Laboratories Companies Market, 2018 - 2030 (USD Million)
• 10.4. Academic and Research Institutes
  • 10.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

• 11.1. Non-Invasive Prenatal Testing Market Share By Region, 2023 & 2030
• 11.2. North America
  • 11.2.1. North America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.2.2. U.S.
    • 11.2.2.1. Key Country Dynamics
    • 11.2.2.2. Target Disease Prevalence
    • 11.2.2.3. Competitive Scenario
    • 11.2.2.4. Regulatory Framework
    • 11.2.2.5. Reimbursement Scenario
    • 11.2.2.6. U.S. Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.2.3. Canada
    • 11.2.3.1. Key Country Dynamics
    • 11.2.3.2. Target Disease Prevalence
    • 11.2.3.3. Competitive Scenario
    • 11.2.3.4. Regulatory Framework
    • 11.2.3.5. Reimbursement Scenario
    • 11.2.3.6. Canada Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
• 11.3. Europe
  • 11.3.1. Europe Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.2. Germany
    • 11.3.2.1. Key Country Dynamics
    • 11.3.2.2. Target Disease Prevalence
    • 11.3.2.3. Competitive Scenario
    • 11.3.2.4. Regulatory Framework
    • 11.3.2.5. Reimbursement Scenario
    • 11.3.2.6. Germany Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.3. UK
    • 11.3.3.1. Key Country Dynamics
    • 11.3.3.2. Target Disease Prevalence
    • 11.3.3.3. Competitive Scenario
    • 11.3.3.4. Regulatory Framework
    • 11.3.3.5. Reimbursement Scenario
    • 11.3.3.6. UK Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.4. France
    • 11.3.4.1. Key Country Dynamics
    • 11.3.4.2. Target Disease Prevalence
    • 11.3.4.3. Competitive Scenario
    • 11.3.4.4. Regulatory Framework
    • 11.3.4.5. Reimbursement Scenario
    • 11.3.4.6. France Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.5. Italy
    • 11.3.5.1. Key Country Dynamics
    • 11.3.5.2. Target Disease Prevalence
    • 11.3.5.3. Competitive Scenario
    • 11.3.5.4. Regulatory Framework
    • 11.3.5.5. Reimbursement Scenario
    • 11.3.5.6. Italy Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.6. Spain
    • 11.3.6.1. Key Country Dynamics
    • 11.3.6.2. Target Disease Prevalence
    • 11.3.6.3. Competitive Scenario
    • 11.3.6.4. Regulatory Framework
    • 11.3.6.5. Reimbursement Scenario
    • 11.3.6.6. Spain Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.7. Denmark
    • 11.3.7.1. Key Country Dynamics
    • 11.3.7.2. Target Disease Prevalence
    • 11.3.7.3. Competitive Scenario
    • 11.3.7.4. Regulatory Framework
    • 11.3.7.5. Reimbursement Scenario
    • 11.3.7.6. Denmark Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.8. Sweden
    • 11.3.8.1. Key Country Dynamics
    • 11.3.8.2. Target Disease Prevalence
    • 11.3.8.3. Competitive Scenario
    • 11.3.8.4. Regulatory Framework
    • 11.3.8.5. Reimbursement Scenario
    • 11.3.8.6. Sweden Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3.9. Norway
    • 11.3.9.1. Key Country Dynamics
    • 11.3.9.2. Target Disease Prevalence
    • 11.3.9.3. Competitive Scenario
    • 11.3.9.4. Regulatory Framework
    • 11.3.9.5. Reimbursement Scenario
    • 11.3.9.6. Norway Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
• 11.4. Asia Pacific
  • 11.4.1. Asia Pacific Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.2. Japan
    • 11.4.2.1. Key Country Dynamics
    • 11.4.2.2. Target Disease Prevalence
    • 11.4.2.3. Competitive Scenario
    • 11.4.2.4. Regulatory Framework
    • 11.4.2.5. Reimbursement Scenario
    • 11.4.2.6. Japan Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.3. China
    • 11.4.3.1. Key Country Dynamics
    • 11.4.3.2. Target Disease Prevalence
    • 11.4.3.3. Competitive Scenario
    • 11.4.3.4. Regulatory Framework
    • 11.4.3.5. Reimbursement Scenario
    • 11.4.3.6. China Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.4. India
    • 11.4.4.1. Key Country Dynamics
    • 11.4.4.2. Target Disease Prevalence
    • 11.4.4.3. Competitive Scenario
    • 11.4.4.4. Regulatory Framework
    • 11.4.4.5. Reimbursement Scenario
    • 11.4.4.6. India Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.5. South Korea
    • 11.4.5.1. Key Country Dynamics
    • 11.4.5.2. Target Disease Prevalence
    • 11.4.5.3. Competitive Scenario
    • 11.4.5.4. Regulatory Framework
    • 11.4.5.5. Reimbursement Scenario
    • 11.4.5.6. South Korea Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.6. Australia
    • 11.4.6.1. Key Country Dynamics
    • 11.4.6.2. Target Disease Prevalence
    • 11.4.6.3. Competitive Scenario
    • 11.4.6.4. Regulatory Framework
    • 11.4.6.5. Reimbursement Scenario
    • 11.4.6.6. Australia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4.7. Thailand
    • 11.4.7.1. Key Country Dynamics
    • 11.4.7.2. Target Disease Prevalence
    • 11.4.7.3. Competitive Scenario
    • 11.4.7.4. Regulatory Framework
    • 11.4.7.5. Reimbursement Scenario
    • 11.4.7.6. Thailand Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
• 11.5. Latin America
  • 11.5.1. Latin America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.5.2. Brazil
    • 11.5.2.1. Key Country Dynamics
    • 11.5.2.2. Target Disease Prevalence
    • 11.5.2.3. Competitive Scenario
    • 11.5.2.4. Regulatory Framework
    • 11.5.2.5. Reimbursement Scenario
    • 11.5.2.6. Brazil Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.5.3. Mexico
    • 11.5.3.1. Key Country Dynamics
    • 11.5.3.2. Target Disease Prevalence
    • 11.5.3.3. Competitive Scenario
    • 11.5.3.4. Regulatory Framework
    • 11.5.3.5. Reimbursement Scenario
    • 11.5.3.6. Mexico Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.5.4. Argentina
    • 11.5.4.1. Key Country Dynamics
    • 11.5.4.2. Target Disease Prevalence
    • 11.5.4.3. Competitive Scenario
    • 11.5.4.4. Regulatory Framework
    • 11.5.4.5. Reimbursement Scenario
    • 11.5.4.6. Argentina Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
• 11.6. MEA
  • 11.6.1. MEA Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.6.2. South Africa
    • 11.6.2.1. Key Country Dynamics
    • 11.6.2.2. Target Disease Prevalence
    • 11.6.2.3. Competitive Scenario
    • 11.6.2.4. Regulatory Framework
    • 11.6.2.5. Reimbursement Scenario
    • 11.6.2.6. South Africa Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.6.3. Saudi Arabia
    • 11.6.3.1. Key Country Dynamics
    • 11.6.3.2. Target Disease Prevalence
    • 11.6.3.3. Competitive Scenario
    • 11.6.3.4. Regulatory Framework
    • 11.6.3.5. Reimbursement Scenario
    • 11.6.3.6. Saudi Arabia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.6.4. UAE
    • 11.6.4.1. Key Country Dynamics
    • 11.6.4.2. Target Disease Prevalence
    • 11.6.4.3. Competitive Scenario
    • 11.6.4.4. Regulatory Framework
    • 11.6.4.5. Reimbursement Scenario
    • 11.6.4.6. UAE Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.6.5. Kuwait
    • 11.6.5.1. Key Country Dynamics
    • 11.6.5.2. Target Disease Prevalence
    • 11.6.5.3. Competitive Scenario
    • 11.6.5.4. Regulatory Framework
    • 11.6.5.5. Reimbursement Scenario
    • 11.6.5.6. Kuwait Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

• 12.1. Participant's overview
• 12.2. Financial performance
• 12.3. Participant categorization
  • 12.3.1. Market Leaders
  • 12.3.2. Non-Invasive Prenatal Testing market Share Analysis, 2023
  • 12.3.3. Company Profiles
    • 12.3.3.1. Genesis Genetics (CooperSurgical, Inc.)
    • 12.3.3.1.1. Company Overview
    • 12.3.3.1.2. Financial Performance
    • 12.3.3.1.3. Product Benchmarking
    • 12.3.3.1.4. Strategic Initiatives
    • 12.3.3.2. Natera, Inc.
    • 12.3.3.2.1. Company Overview
    • 12.3.3.2.2. Financial Performance
    • 12.3.3.2.3. Product Benchmarking
    • 12.3.3.2.4. Strategic Initiatives
    • 12.3.3.3. Centogene N.V.
    • 12.3.3.3.1. Company Overview
    • 12.3.3.3.2. Financial Performance
    • 12.3.3.3.3. Product Benchmarking
    • 12.3.3.3.4. Strategic Initiatives
    • 12.3.3.4. Eurofins Scientific
    • 12.3.3.4.1. Company Overview
    • 12.3.3.4.2. Financial Performance
    • 12.3.3.4.3. Product Benchmarking
    • 12.3.3.4.4. Strategic Initiatives
    • 12.3.3.5. MedGenome Labs Ltd.
    • 12.3.3.5.1. Company Overview
    • 12.3.3.5.2. Financial Performance
    • 12.3.3.5.3. Product Benchmarking
    • 12.3.3.5.4. Strategic Initiatives
    • 12.3.3.6. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
    • 12.3.3.6.1. Company Overview
    • 12.3.3.6.2. Financial Performance
    • 12.3.3.6.3. Product Benchmarking
    • 12.3.3.6.4. Strategic Initiatives
    • 12.3.3.7. Myriad Women's Health, Inc. (Counsyl, Inc.)
    • 12.3.3.7.1. Company Overview
    • 12.3.3.7.2. Financial Performance
    • 12.3.3.7.3. Product Benchmarking
    • 12.3.3.7.4. Strategic Initiatives
    • 12.3.3.8. Progenity, Inc.
    • 12.3.3.8.1. Company Overview
    • 12.3.3.8.2. Financial Performance
    • 12.3.3.8.3. Product Benchmarking
    • 12.3.3.8.4. Strategic Initiatives
    • 12.3.3.9. Qiagen
    • 12.3.3.9.1. Company Overview
    • 12.3.3.9.2. Financial Performance
    • 12.3.3.9.3. Product Benchmarking
    • 12.3.3.9.4. Strategic Initiatives
    • 12.3.3.10. Laboratory Corp. of America Holdings
    • 12.3.3.10.1. Company Overview
    • 12.3.3.10.2. Financial Performance
    • 12.3.3.10.3. Product Benchmarking
    • 12.3.3.10.4. Strategic Initiatives
    • 12.3.3.11. Illumina, Inc. (Verinata Health, Inc.)
    • 12.3.3.11.1. Company Overview
    • 12.3.3.11.2. Financial Performance
    • 12.3.3.11.3. Product Benchmarking
    • 12.3.3.11.4. Strategic Initiatives
    • 12.3.3.12. Quest Diagnostics, Inc.
    • 12.3.3.12.1. Company Overview
    • 12.3.3.12.2. Financial Performance
    • 12.3.3.12.3. Product Benchmarking
    • 12.3.3.12.4. Strategic Initiatives
  • 12.3.4. Strategy Mapping
    • 12.3.4.1. Expansion
    • 12.3.4.2. Acquisition
    • 12.3.4.3. Collaborations
    • 12.3.4.4. Product Type/Product Launch
    • 12.3.4.5. Partnerships
    • 12.3.4.6. Others